![Patient with Agitation associated with dementia due to Alzheimer's disease being consoled by her caregiver. Patient with Agitation associated with dementia due to Alzheimer's disease being consoled by her caregiver.](/sites/g/files/qhldwo8606/files/styles/max_2048/public/2024-01/aad_hero_desktop.jpg?itok=3siAxkj3)
The First and Only FDA-approved Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease
Limitations of Use: REXULTI is not indicated as an as needed (“prn”) treatment for agitation associated with dementia due to Alzheimer’s disease.
Hypothetical patient and caregiver.
The First and Only FDA-approved Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease
Limitations of Use: REXULTI is not indicated as an as needed (“prn”) treatment for agitation associated with dementia due to Alzheimer’s disease.
![Patient with Agitation associated with dementia due to Alzheimer's disease being consoled by her caregiver. Patient with Agitation associated with dementia due to Alzheimer's disease being consoled by her caregiver.](/sites/g/files/qhldwo8606/files/styles/max_1300x1300/public/2024-01/aad_hero_mob.jpg?itok=jleO0P0A)
Hypothetical patient and caregiver.